In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Thursday, 5:13 AM

March 26, 2026

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

Social Media Reckoning

A Los Angeles jury found Meta and Google liable for addictive social media designs, awarding $6 million to a 20-year-old user.

This is the first of thousands of lawsuits targeting Meta, Google, TikTok, and Snap, alleging harm to youth mental health. Another case in New Mexico imposed a $375 million verdict on Meta.

The suits challenge 1996 Communications Decency Act immunity by focusing on product design features like infinite scroll and push notifications. Plaintiffs seek changes including age verification and parental controls.

Meta and Alphabet plan to appeal, emphasizing existing safety tools. These cases could drive regulatory changes affecting platforms' ad-driven revenue models and echo past legal battles against Big Tobacco and opioid manufacturers.

Sources: Bloomberg, AP News, WallStreetJournal

Hormuz Toll & Troop Surge

Iran plans a law to charge ships up to $2 million for passing through the Strait of Hormuz, halting most non-Iranian/Chinese shipping amid U.S.-Israeli strikes.

The U.S. has deployed about 6,000 troops, including two Marine Expeditionary Units and the 82nd Airborne, raising fears of a ground invasion. Thirteen U.S. servicemembers have died, nearly 300 wounded.

Trump seeks to end the war within 4 to 6 weeks, aiming for resolution before a mid-May China summit, but Iran rejects direct talks.

Oil prices surged, with Brent crude over $114 and U.S. crude up 30%. The White House considers economic fallout if oil nears $200 per barrel.

Sources: Bloomberg, Bloomberg, Bloomberg, WallStreetJournal

Nomination Gridlock

Dr. Casey Means, nominated for U.S. surgeon general, faces strong Republican opposition in the Senate. She needs unanimous Republican support on the Senate health committee to advance, as Democrats oppose her.

Means, 38, trained at Stanford, left surgical residency for holistic health, promoting lifestyle changes and parental vaccine choice. Her medical license is inactive, and she has questioned vaccine recommendations, drawing criticism.

Her hearing was delayed four months; the process has taken nearly 300 days, almost double the average. Key Republicans, including Sens. Murkowski, Collins, Tillis, and McConnell, are undecided or leaning no.

Former Surgeon General Jerome Adams called her unqualified. The White House supports her amid broader health department instability.

Sources: WallStreetJournal, Medpagetoday, Timesdaily

AI Agent Revolution

OpenAI invested in Isara, a startup founded in June 2025 by Eddie Zhang and Henry Gasztowtt, valued at $650 million.

Isara builds AI agents that collaborate in swarms to tackle complex problems in finance, biotech, and geopolitics, coordinating 2,000 agents to forecast gold prices. T

he startup raised $94 million from investors including Michael Ovitz and Stanley Druckenmiller. Isara aims to sell predictive software primarily to investment and financial firms.

OpenAI backs Isara to compete with Anthropic and Google DeepMind and to advance multi-agent AI systems focused on business services. Isara attracts top researchers and spearheads a shift from single AI models to autonomous collaborative AI teams handling interconnected data.

Sources: WallStreetJournal, Republicworld

Immune Brake Discovery

Researchers identified SLAMF6, an immune checkpoint on T cells that suppresses their cancer-fighting ability independently of tumors.

Unlike PD1/PDL1 inhibitors, SLAMF6 limits T cell strength and induces exhaustion. New monoclonal antibodies developed to block SLAMF6 activated more human T cells, increased resilient immune cells, reduced exhaustion, and triggered robust anti-tumor responses in mice.

These antibodies outperform prior SLAMF6 strategies and may benefit patients resistant to existing immunotherapies, alone or combined with other treatments.

The team plans early clinical trials for solid tumors and blood cancers to assess safety and efficacy. This discovery offers a novel target for cancer immunotherapy.

Sources: SciTechDaily

Collagen’s Real Impact

A review of 16 systematic reviews and 113 clinical trials with nearly 8,000 participants found collagen supplements improve skin elasticity, hydration, and reduce osteoarthritis pain and stiffness, especially with prolonged use.

Collagen showed modest benefits for muscle mass, structure, and tendon composition, indicating a role in healthy aging. It did not aid post-exercise recovery, muscle soreness, tendon strength, or sports performance.

Evidence on collagen’s impact on oral health, cholesterol, blood pressure, and blood sugar was inconclusive. Improved recent results may reflect better formulations and methods.

Collagen supports skin and joint health but is not a cure-all. Further research is needed on dosing, long-term effects, and collagen types.

Sources: SciTechDaily

“If one wants a comfortable seat on the riverboat of life, he ought to pay his fare in genuine ability, rather than just swaggering aboard and demanding the captain's chair.”

Baked with love,

Anna Eisenberg ❤️